Anglogold Ashanti Ltd (AU) 16.22 $AU Is Barrick Gold

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Anglogold Ashanti Ltd (AU) 16.22 $AU

Is Barrick Gold (ABX) the Most Efficient Gold Miner?
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 4:20PM CDT
Barrick Gold (ABX) is having an impressive run this year, thanks to rally in gold prices and its aggressive cost management actions.
ABX: 20.22 (+0.61), KGC: 5.16 (-0.02), AU: 16.22 (-0.44), GFI: 4.22 (-0.16), NEM: 35.89 (+0.10), IAG: 3.85 (-0.03), GG: 18.05 (-0.01)

After Yesterday's Rally of 2.55% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Jun 02, 2:56PM CDT
AngloGold Ashanti (NYSE:AU) traded in a range yesterday that spanned from a low of $13.78 to a high of $14.19. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $14.06 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AU: 16.22 (-0.44)

Look for Shares of AngloGold Ashanti to Potentially Pullback after Yesterday's 2.55% Rise
Comtex SmarTrend(R) - Thu Jun 02, 2:55PM CDT
AngloGold Ashanti (NYSE:AU) traded in a range yesterday that spanned from a low of $13.78 to a high of $14.19. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $14.06 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AU: 16.22 (-0.44)

Uptrend Call Working As AngloGold Ashanti Stock Rises 91.9% (AU)
Comtex SmarTrend(R) - Wed May 18, 12:09AM CDT
SmarTrend identified an Uptrend for AngloGold Ashanti (NYSE:AU) on January 7th, 2016 at $7.81. In approximately 4 months, AngloGold Ashanti has returned 91.93% as of today's recent price of $14.99.
AU: 16.22 (-0.44)

New Strong Sell Stocks for May 17th
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:18AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
BUD: 123.94 (-1.55), ACAT: 15.85 (+0.01), MTGE: 15.80 (-0.19), AU: 16.22 (-0.44), ABBV: 59.93 (-1.07)

Watch for AngloGold Ashanti to Potentially Pullback After Gaining 2.20% Yesterday
Comtex SmarTrend(R) - Fri May 13, 1:58PM CDT
AngloGold Ashanti (NYSE:AU) traded in a range yesterday that spanned from a low of $15.32 to a high of $15.67. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $15.55 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AU: 16.22 (-0.44)

Uptrend Call Working As AngloGold Ashanti Stock Rises 80.7% (AU)
Comtex SmarTrend(R) - Tue May 10, 12:39PM CDT
SmarTrend identified an Uptrend for AngloGold Ashanti (NYSE:AU) on January 7th, 2016 at $7.81. In approximately 4 months, AngloGold Ashanti has returned 80.67% as of today's recent price of $14.11.
AU: 16.22 (-0.44)

AngloGold Ashanti Generates Strong Cash Flow in Q1; Operations Solid
Marketwired - Mon May 09, 12:22AM CDT
JOHANNESBURG, SOUTH AFRICA--(Marketwired - May 09, 2016) - AngloGold Ashanti (NYSE: AU) today announced strong free cash flow in the first quarter as an ongoing focus on cost management, and leverage to weaker currencies, yielded positive results and improved margins.
AU: 16.22 (-0.44)

Zonte Metals prepares to proceed to Special Court regarding its Gramalote Target Application
CNW Group - Mon May 02, 3:30PM CDT
TSXV: ZON
ZON.VN: 0.085 (-0.005), AU: 16.22 (-0.44)

Shares of AU Up 86.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 28, 12:13AM CDT
SmarTrend identified an Uptrend for AngloGold Ashanti (NYSE:AU) on January 7th, 2016 at $7.81. In approximately 4 months, AngloGold Ashanti has returned 86.30% as of today's recent price of $14.55.
AU: 16.22 (-0.44)

AngloGold Ashanti Falls 1.68% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Apr 26, 4:25PM CDT
AngloGold Ashanti (NYSE:AU) traded in a range yesterday that spanned from a low of $14.19 to a high of $14.63. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $14.53 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AU: 16.22 (-0.44)

After Yesterday's Decline of 1.68%, AngloGold Ashanti Offers Investors Better Value
Comtex SmarTrend(R) - Tue Apr 26, 4:24PM CDT
AngloGold Ashanti (NYSE:AU) traded in a range yesterday that spanned from a low of $14.19 to a high of $14.63. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $14.53 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AU: 16.22 (-0.44)

New Strong Sell Stocks for April 26th
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 7:40AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
AMX: 11.67 (-0.42), ANW: 6.03 (+0.01), AU: 16.22 (-0.44), AGU: 93.64 (-0.28), AIR: 23.36 (-0.83)

Shares of AU Up 100.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 20, 12:40PM CDT
SmarTrend identified an Uptrend for AngloGold Ashanti (NYSE:AU) on January 7th, 2016 at $7.81. In approximately 3 months, AngloGold Ashanti has returned 100.51% as of today's recent price of $15.66.
AU: 16.22 (-0.44)

Syngenta Downgraded to Hold on Agro-Industry Headwinds
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:45PM CDT
On Apr 13, 2016, Zacks Investment Research downgraded Syngenta AG (SYT) to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
SYT: 80.60 (-0.57), LMNR: 18.81 (+0.73), AU: 16.22 (-0.44), AGI: 7.68 (-0.19)

AngloGold Ashanti Up 102.3% Since SmarTrend Uptrend Call (AU)
Comtex SmarTrend(R) - Tue Apr 12, 12:37PM CDT
SmarTrend identified an Uptrend for AngloGold Ashanti (NYSE:AU) on January 7th, 2016 at $7.81. In approximately 3 months, AngloGold Ashanti has returned 102.26% as of today's recent price of $15.80.
AU: 16.22 (-0.44)

Zonte Metals updates legal progress on the Gramalote Target Application, Colombia
CNW Group - Tue Apr 12, 6:52AM CDT
TSXV: ZON
ZON.VN: 0.085 (-0.005), BTG: 2.18 (+0.12), AU: 16.22 (-0.44), BTO.TO: 2.79 (+0.14)

Upgrade Alert for AngloGold Ashanti (AU)
Comtex SmarTrend(R) - Tue Apr 12, 3:03AM CDT
AngloGold Ashanti (NYSE:AU) was upgraded from Sector Perform to Outperform at RBC Capital today. The stock closed yesterday at $15.57 on volume of 5.7 million shares, below average daily volume of 6.2 million. AngloGold Ashanti (NYSE:AU) defies analysts with a current price ($15.57) 27.7% above its average consensus price target of $11.26. AngloGold Ashanti shares have support at the 50-day moving average (MA) of $12.36 and additional support at the 200-day MA of $8.79.
AU: 16.22 (-0.44)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 39

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 46

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 48

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 50

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 58

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Cemtrex's Stock Surge Sparks Interest in Leading Movers

Updated Category News Views 117

Cemtrex Experiences Notable Share Surge Shares of Cemtrex, Inc. CETX have seen a significant uptick amid pre-market trading. This boost comes on the heels of better-than-expected sales in the latest quarter, reporting an impressive $18.10 million in sales, surpassing the general analyst expectation of $16.39 million. This remarkable performance in sales has sparked...

Continue Reading
Exciting New PharmD-MBA Pathway Combines Pharmacy and Business

Updated Category News Views 193

Collaboration between Cal Poly Pomona and Western University In an exciting move, Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences have teamed up to create a groundbreaking pathway for aspiring healthcare professionals. This innovative PharmD-MBA program combines the fields of pharmacy and business, providing a unique...

Continue Reading
Kaskela Law Investigates Stock Misconduct in Stanley Black & Decker

Updated Category News Views 155

Overview of the Investigation by Kaskela Law LLC Kaskela Law LLC has announced an important investigation focused on Stanley Black & Decker, Inc. (NYSE: SWK) concerning allegations of potential securities fraud. This inquiry is primarily aimed at safeguarding the interests of long-term investors who hold shares in this well-known manufacturing company. Details Surrounding...

Continue Reading
Legend Biotech's Carvykti: A Leading Force in Cancer Treatment

Updated Category News Views 90

Redburn's Positive Outlook for Legend Biotech Recently, Redburn-Atlantic began covering Legend Biotech Corp. (NASDAQ: LEGN) with a favorable Buy rating and set a price target of $86.00 for the stock. This biotechnology company has made significant strides, particularly with the recent approval of its innovative product, Carvykti, designed for the treatment of multiple...

Continue Reading
Transforming the Anti-Obesity Drug Market for Future Success

Updated Category News Views 132

Global Anti-Obesity Drug Market Overview As global health concerns rise, the demand for anti-obesity drugs is surging. Recent reports estimate that the anti-obesity drug market will soar to USD 82.55 billion in the coming years. This impressive growth, fueled by an anticipated compound annual growth rate (CAGR) of 18.01%, signals a crucial moment for pharmaceutical...

Continue Reading